Emboguard
Payments companies reported to CMS as associated with Emboguard. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Emboguard, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Emboguard
These are the largest totals companies reported as associated with Emboguard. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ansaar Rai | Morgantown, WV | Neuroradiology | $116,938.59 |
| Edgar Samaniego | Iowa City, IA | Vascular & Interventional Radiology | $92,521.90 |
| Eytan Raz | New York, NY | Neuroradiology | $85,523.90 |
| Jay Howington | Savannah, GA | Neurological Surgery | $76,855.50 |
| Sudhakar Satti | Paoli, PA | Neuroradiology | $59,217.12 |
| Shahram Majidi | New York, NY | Neurological Surgery | $57,440.94 |
| Ricardo Hanel | Jacksonville, FL | Neurological Surgery | $56,833.84 |
| Ryan Kellogg | Charlottesville, VA | Neurological Surgery | $55,157.17 |
| Blaise Baxter | San Francisco, CA | Vascular & Interventional Radiology | $53,255.32 |
| Reade Deleacy | New York, NY | Neurological Surgery | $50,714.28 |
Prescribed Emboguard?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.